Chronic Hand Eczema: Clinical Insights, Patient Experience, and Emerging Therapeutics - Episode 1
Prevalence, Presentation, and the CHE Patient Journey
An expert discusses how chronic hand eczema (CHE) is a common condition affecting 1% to 5% of adults and is defined as hand eczema lasting at least 3 months or relapsing at least 2 times per year, distinct from atopic dermatitis.
Video content above is prompted by the following:
Overview of CHE
Panel Introduction
This summary features insights from Raj Chovatiya, MD, PhD, a dermatology specialist discussing CHE diagnosis, clinical presentation, and treatment approaches.
Key Themes:
- Definition and prevalence: CHE is defined as hand eczema lasting at least 3 months or relapsing at least 2 times per year, with point prevalence of 1% to 5% in adults and lifetime prevalence around 15%.
- Differentiation from atopic dermatitis: While atopic dermatitis can manifest on hands, CHE encompasses broader etiologies and clinical presentations.
- Disease burden: CHE presents significant functional limitations due to its impact on daily activities and occupational performance.
Notable Insights:
Dr Chovatiya emphasized that CHE is "common, burdensome, [and] highly symptomatic for patients, and something that we're probably missing the boat on in terms of really adding a name to it to get to the next step of treatment."
